Search research articles
Contact Us
Filters
Showing results (181-190 of 211) with videos related to
Page
of 22
Sort By:
Blood Advances
|
November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma
Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
The New England Journal of Medicine
|
December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Meletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Leukemia
|
December 14, 2018
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Noemi Puig, Bruno Paiva, Marta Lasa, et al.
Leukemia
|
June 2, 2020
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Juan-José Garcés, Gabriel Bretones, Leire Burgos, et al.
Blood Advances
|
August 5, 2025
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
Maria-Victoria Mateos, Suzanne Trudel, Hang Quach, et al.
The Lancet. Haematology
|
June 28, 2025
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network
Niels W C J van de Donk, Philippe Moreau, Jesús F San-Miguel, et al.
The New England Journal of Medicine
|
June 6, 2022
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau, Alfred L Garfall, Niels W C J van de Donk, et al.
Hemasphere
|
October 13, 2025
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform
Adrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino, et al.
Blood
|
April 24, 2020
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Cristina Perez, Cirino Botta, Aintzane Zabaleta, et al.
Cancer Cell
|
November 15, 2022
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Romanos Sklavenitis-Pistofidis, Michelle P Aranha, Robert A Redd, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 211) with videos related to
Sort By:
Page
of 22
Blood Advances
|
November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma
Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
The New England Journal of Medicine
|
December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Meletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Leukemia
|
December 14, 2018
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Noemi Puig, Bruno Paiva, Marta Lasa, et al.
Leukemia
|
June 2, 2020
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Juan-José Garcés, Gabriel Bretones, Leire Burgos, et al.
Blood Advances
|
August 5, 2025
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
Maria-Victoria Mateos, Suzanne Trudel, Hang Quach, et al.
The Lancet. Haematology
|
June 28, 2025
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network
Niels W C J van de Donk, Philippe Moreau, Jesús F San-Miguel, et al.
The New England Journal of Medicine
|
June 6, 2022
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau, Alfred L Garfall, Niels W C J van de Donk, et al.
Hemasphere
|
October 13, 2025
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform
Adrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino, et al.
Blood
|
April 24, 2020
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Cristina Perez, Cirino Botta, Aintzane Zabaleta, et al.
Cancer Cell
|
November 15, 2022
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Romanos Sklavenitis-Pistofidis, Michelle P Aranha, Robert A Redd, et al.
Page
of 22